Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp

British Journal of Dermatology

Volumn 141, Issue 3, 1999, Pages 481-491

  Bayne, Ellen K ^a   Flanagan, J ^a   Einstein, M ^a   Ayala, J ^a   Chang, B ^a   Azzolina, B ^a   Whiting, D A ^b   Mumford, R A ^a   Thiboutot, D ^c   Singer, I I ^a   Harris, G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

5 reductase; Dihydrotestosterone; Hair follicle; Human scalp; Immunolocalization

Indexed keywords

ISOENZYME; STEROID 5ALPHA REDUCTASE;

ALOPECIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; EPITOPE MAPPING; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SCALP; SCALP HAIR;

ADULT; ALOPECIA; ANIMALS; ANTIBODIES, MONOCLONAL; HAIR FOLLICLE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; MALE; MICE; RABBITS; SCALP; SEBACEOUS GLANDS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0032884416     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03042.x     Document Type: Article

References (27)

1. Hamilton JB. Male hormone stimulation is a prerequisitc and an incitant in common baldness. Am J Anat 1942; 71: 451-80.
2. Imperato-McGinley J, Guerrero L, Gautier T et al. Steroid 5αreductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974; 27: 1213-15.
3. Imperato-McGinley J, Gautier T, Inherited 5α-reductase deficiency in man. Trends Genet 1986; 2: 130-3.
4. Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase 2 deficiency. Endocrin Rev 1993; 14: 577-93.
5. Andersson S, Berman DM, Jenkins EP et al. Deletion of steroid 5αreductase 2 gene in male pseudohermaphroditism. Nature 1991; 354: 159-61.
6. Harris G, Azzolina B, Buginsky W et al. Identification and selective inhibition of an isozyme of steroid 5α-reductase in human scalp. Proc Natl Acad Sci USA 1992; 89: 10787-91.
7. Dallob AL, Sadick NS, Unger W et al. The effect of finasteride, a 5αreductase inhibitor, on scalp skin testosterone and dihydrotesiosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 1994; 79: 703-6.
8. Waldstreicher J, Fiedler V, Hordinsky M et al. Effects of finasteride on dihydrotestosterone content of scalp skin in men with male pattern baldness. J Invest Dermatol 1994; 104: 615 (Abstr.).
9. Kaufman KD. Clinical studies on the effects of oral finasteride, a type II 5α-reductase inhibitor, on scalp hair in men with male pattern baldness. In: Hair Research for the Next Millenium (van Neste DJ, Randall VA, eds). Amsterdam: Elsevier, 1996: 363-5.
10. Kitagawa T, Aikawa T. Enzyme coupled immunoassay of insulin using a novel coupling reagent. J Biochem 1976; 79: 233-6.
11. Miller DK, Ayala JM, Egger LA et al. Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells. J Biol Chem 1993; 268: 18062-9.
12. Patel S, Einstein M, Geissler W et al. Immunohistochemical analysis of steroid 5α-reductase type 1 in human scalp and prostate. Ann NY Acad Sci 1996; 784: 27-39.
13. Andersson S. Jornvall H. Sex differences in cytochrome P-450 dependent 25-hydroxylation of C27-steroids and vitamin D3 in rat liver microsomes. J Biol Chem 1986; 261: 16932-6.
14. Andersson S, Russell DW. Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci USA 1990; 87: 3640-4.
15. Bakshi RK, Rasmusson GH, Patel GF et al. 4-aza-3-axo-5α-androst1-ene-17β-N-aryl-carboxamides as dual inhibitors of human type 1 and 2 steroid 5α-reductatases. Dramatic effect of N-aryl substituents on type 1 and 2 5α-reducase inhibitory potency. J Med Chem 1995; 38: 3189-92.
16. McLean JW, Nakane PK. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem 1974; 22: 1077-83.
17. Bayne EK, Rupp EA, Limjuco G et al. Immunocytochemical detection of interleukin 1 within stimulated human monocytes. J Exp Med 1986; 163: 1267-80.
18. Shu S, Ju C, Fan L. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988; 85: 169-71.
19. Eichler W, Dreher M, Hoffmann R et al. Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol 1995; 133: 371-6.
20. Thiboutol D, Harris G, Iles V et al. Activity of the type 1 5αreductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995; 105: 209-14.
21. Russell DW, Wiley EI, Whiting DA. Expression of steroid 5α-reductase I and II in scalp skin in normal controls and in androgenic atopecia. In: Hair Research for the Next Millenium (van Neste DJ, Randall VA, eds). Amsterdam: Elsevier, 1996; 339-40.
22. Sawaya ME, Price VH. Different levels of 5α-reductase type I and II. aromarase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109: 296-300.
23. Liang T. Hoyer S. Yu R et al. Imunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 1993; 100: 663-6.
24. Choudhry R, Hodgins MB, van der Kwast TH et al. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992; 133: 467-75.
25. Itami S, Kurata S, Sonoda T et al. Interaction between dermal papilla cells and follicular epithelial cells in vitro: effect of androgen. Br J Dermatol 1995; 132: 527-32.
26. Obana N, Chang C, Uno H. Inhibition of hair growth by testosterone in the presence of dermal papilla cells from the frontal bald scalp of the postpubertal stumptailed macaque. Endocrinology 1997; 138: 356-61.
27. Gormley GJ, Stoner E, Bruskewitz RC et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992; 327: 1185-91.